The surprising impact of anxiety drugs on pancreatic cancer survival
Benzodiazepines are drugs commonly used to help people with anxiety and sleep problems.
People with cancer often take them to relieve anxiety caused by their...
Scientists find new way to starve pancreatic tumors
Pancreatic cancer, notorious for its low survival rates and unique metabolic attributes, might be on the verge of meeting a novel adversary.
Scientists from Sanford...
New drug combo could starve pancreatic cancer, study shows
When it comes to pancreatic cancer, finding effective treatments has always been a notoriously tough nut to crack for the medical community.
But now, scientists...
New vaccine may help treat breast, liver, and pancreatic cancers
Researchers from the University of Massachusetts Amherst have propelled the domain of cancer immunotherapy by theoretically demonstrating that a protein antigen from a childhood...
Scientists find important cause of of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC), a very aggressive type of pancreatic cancer, is known as a silent killer due to its poor survival rate of...
Scientists find new way to treat pancreatic cancer
Pancreatic cancer stands as one of the deadliest forms of cancer, often diagnosed at advanced stages, making early intervention challenging and prognosis poor.
Given its...
Scientists find a new way to tell pancreatic cancer from inflammation
Pancreatic cancer is often mistaken for chronic inflammation of the pancreas, which is a problem because the treatment for each is very different.
This mix-up...
Gut microbes could offer new way to detect pancreatic cancer
Pancreatic cancer is notoriously difficult to diagnose early and treat effectively. It ranks as the 12th most common cancer globally, with a dismal survival...
Researchers discover super-enhancer driving pancreatic cancer growth
Researchers at the Salk Institute have identified a "super-enhancer" that fuels the rapid growth of pancreatic ductal adenocarcinoma (PDAC), the most common type of...
New method cuts opioid use in half for pancreatic cancer surgery patients
Researchers at The University of Texas MD Anderson Cancer Center have successfully reduced inpatient opioid use by 50% after pancreatic cancer surgery, according to...